Amneal Pharmaceuticals, Inc.
AMRX
Price:
$8.39
Market Cap:
$3.88B
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, p...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-07
Stock Exchange
NYSE
Ticker
AMRX
PE Ratio
[-9.76]
ROE
[354.22%]
Current Ratio
[1.38]
Dividend Yield
[0%]
Enterprise Value
[6.31B]
Dividend History
The ROE as of November 2024 (TTM) for Amneal Pharmaceuticals, Inc. (AMRX) is 354.22%
According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 354.22%. This represents a change of -474.93% compared to the average of -94.48% of the last 4 quarters.
Amneal Pharmaceuticals, Inc. (AMRX) Historical ROE (quarterly & annually)
How has AMRX ROE performed in the past?
The mean historical ROE of Amneal Pharmaceuticals, Inc. over the last ten years is -97.29%. The current 354.22% ROE has changed -464.08% with respect to the historical average. Over the past ten years (40 quarters), AMRX's ROE was at its highest in in the March 2018 quarter at 515.35%. The ROE was at its lowest in in the December 2023 quarter at -498.71%.
Average
-97.29%
Median
-65.15%
Minimum
-424.61%
Maximum
19.88%
Amneal Pharmaceuticals, Inc. (AMRX) ROE by Quarter and Year
Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 819.18%
Maximum Annual ROE = 19.88%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -424.61%
| Year | ROE | Change |
|---|---|---|
| 2023 | -424.61% | 206.61% |
| 2022 | -138.49% | -2619.65% |
| 2021 | 5.50% | -72.35% |
| 2020 | 19.88% | -111.42% |
| 2019 | -174.05% | 819.18% |
| 2018 | -18.93% | -56.43% |
| 2017 | -43.46% | -61.17% |
| 2016 | -111.92% | 28.89% |
| 2015 | -86.83% | -Infinity% |
Amneal Pharmaceuticals, Inc. (AMRX) Average ROE
How has AMRX ROE performed in the past?
The current ROE of Amneal Pharmaceuticals, Inc. (AMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-185.87%
5-year avg
-142.35%
10-year avg
-97.29%
Amneal Pharmaceuticals, Inc. (AMRX) ROE vs. Peers
How is AMRX’s ROE compared to its peers?
Amneal Pharmaceuticals, Inc.’s ROE is less than Alkermes plc (26.49%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Intra-Cellular Therapies, Inc. (-9.93%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than Dynavax Technologies Corporation (3.19%), less than Amphastar Pharmaceuticals, Inc. (22.92%), less than Collegium Pharmaceutical, Inc. (40.81%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), greater than ANI Pharmaceuticals, Inc. (-1.60%), less than Phibro Animal Health Corporation (6.59%), less than Procaps Group S.A. (97.17%), less than Silver Spike Investment Corp. (5.74%), less than Eagle Pharmaceuticals, Inc. (17.39%), greater than Evolus, Inc. (-966.29%), less than Agile Therapeutics, Inc. (104.04%), greater than Assertio Holdings, Inc. (-51.19%), greater than AcelRx Pharmaceuticals, Inc. (-39.88%), less than Lifecore Biomedical, Inc. (17.23%),
| Company | ROE | Market cap |
|---|---|---|
| 26.49% | $4.66B | |
| 15.68% | $12.72B | |
| -9.93% | $9.08B | |
| -52.42% | $2.21B | |
| 3.19% | $1.63B | |
| 22.92% | $2.19B | |
| 40.81% | $966.22M | |
| -7.63% | $550.50M | |
| -1.60% | $1.20B | |
| 6.59% | $961.56M | |
| 97.17% | $103.80M | |
| 5.74% | $66.72M | |
| 17.39% | $12.31M | |
| -966.29% | $797.85M | |
| 104.04% | $10.43M | |
| -51.19% | $89.83M | |
| -39.88% | $14.58M | |
| 17.23% | $269.21M |
Build a custom stock screener for Amneal Pharmaceuticals, Inc. (AMRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Amneal Pharmaceuticals, Inc. (AMRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Amneal Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the highest ROE for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 3-year average ROE for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 5-year average ROE for Amneal Pharmaceuticals, Inc. (AMRX)?
How does the current ROE for Amneal Pharmaceuticals, Inc. (AMRX) compare to its historical average?